CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-16 | Qamar Huma Chief Medical Officer | Grant or award · Option (Right to Buy) | +308,465 | 308,465 | ||
| 2024-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −180,204 | $0.65 | $118K | 2,009,869 |
| 2024-01-03 | Upadhyay Arun See Remarks | Shares withheld for taxes | −41,633 | $0.65 | $27K | 349,589 |
| 2024-01-02 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +492,126 | 492,126 | ||
| 2024-01-02 | Upadhyay Arun See Remarks | Grant or award · Option (Right to Buy) | +137,795 | 137,795 | ||
| 2023-09-16 | Upadhyay Arun See Remarks | Shares withheld for taxes | −842 | $0.41 | $345 | 391,222 |
| 2023-06-16 | Upadhyay Arun Chief Scientific Officer | Shares withheld for taxes | −917 | $0.51 | $468 | 392,064 |
| 2023-06-14 | Zhang Junge Director | Purchase | +200,278 | $0.50 | $100K | 1,077,182 |
| 2023-06-09 | Castillo Kirsten Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-06-09 | Fernandes Prabhavathi Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-06-09 | Kompella Uday Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-06-09 | Kumar Ramesh Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-06-09 | WHITTINGTON MARNA C Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-06-09 | Zhang Junge Director | Grant or award · Option (Right to Buy) | +112,205 | 112,205 | ||
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Option exercise | +100,000 | $0.33 | $33K | 2,290,073 |
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Sale | −100,000 | $1.08 | $108K | 2,190,073 |
| 2023-02-16 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −100,000 | 529,764 | ||
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Option exercise | +100,000 | $0.51 | $51K | 2,327,950 |
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Sale | −100,000 | $1.28 | $128K | 2,227,950 |
| 2023-01-17 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −100,000 | 326,543 |
Page 3 of 27 · 525 trades